Literature DB >> 16860003

Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.

Yury Herasimenka1, Paola Cescutti, Giuseppe Impallomeni, Silvia Campana, Giovanni Taccetti, Novella Ravenni, Flavio Zanetti, Roberto Rizzo.   

Abstract

BACKGROUND: In the frame of a research line dedicated to better clarify the role of exopolysaccharides (EPS) in bacterial virulence, EPS produced by species of the Burkholderia cepacia complex (Bcc), namely Burkholderia multivorans, Burkholderia cenocepacia, and a Bcc member of undetermined genomovar, all isolated at the Cystic Fibrosis Regional Centre of Florence (Italy), were investigated for they structural properties.
METHODS: Three strains of B. multivorans, three of B. cenocepacia and one of a Bcc member of undetermined genomovar were isolated from CF patients. The reference strains C1576 and J2315, for genomovar II and III, respectively, were included in the study. The bacteria were grown on solid media, the exopolysaccharides produced were purified, and their structures were determined. In addition, sugar analysis of sputum samples was accomplished to search for EPS produced in vivo.
RESULTS: Six strains out of seven produced the exopolysaccharide cepacian, while one strain of B. multivorans produced a completely different polymer, previously known in the literature as PS1. Two strains synthesised very small amounts of EPS. No definitive evidence for the presence of cepacian in sputum samples was found.
CONCLUSIONS: Most strains examined produced abundant amounts of polysaccharides. Cepacian was the most common EPS isolated and its production was not associated to a particular genomovar.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860003     DOI: 10.1016/j.jcf.2006.06.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  11 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.

Authors:  James E A Zlosnik; Trevor J Hird; Monica C Fraenkel; Leonilde M Moreira; Deborah A Henry; David P Speert
Journal:  J Clin Microbiol       Date:  2008-02-06       Impact factor: 5.948

3.  Distribution of cepacian biosynthesis genes among environmental and clinical Burkholderia strains and role of cepacian exopolysaccharide in resistance to stress conditions.

Authors:  Ana S Ferreira; Jorge H Leitão; Inês N Silva; Pedro F Pinheiro; Sílvia A Sousa; Christian G Ramos; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

4.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

Review 5.  Two quorum sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex.

Authors:  Angela Suppiger; Nadine Schmid; Claudio Aguilar; Gabriella Pessi; Leo Eberl
Journal:  Virulence       Date:  2013-07-01       Impact factor: 5.882

Review 6.  Bacterial Adaptation during Chronic Respiratory Infections.

Authors:  Louise Cullen; Siobhán McClean
Journal:  Pathogens       Date:  2015-03-02

Review 7.  Host evasion by Burkholderia cenocepacia.

Authors:  Shyamala Ganesan; Umadevi S Sajjan
Journal:  Front Cell Infect Microbiol       Date:  2012-01-11       Impact factor: 5.293

8.  Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.

Authors:  Ruth R Miller; Trevor J Hird; Patrick Tang; James E A Zlosnik
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

9.  Response of Burkholderia cenocepacia H111 to micro-oxia.

Authors:  Gabriella Pessi; Rubina Braunwalder; Alexander Grunau; Ulrich Omasits; Christian H Ahrens; Leo Eberl
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

10.  Versatility of the Burkholderia cepacia complex for the biosynthesis of exopolysaccharides: a comparative structural investigation.

Authors:  Bruno Cuzzi; Yury Herasimenka; Alba Silipo; Rosa Lanzetta; Gianfranco Liut; Roberto Rizzo; Paola Cescutti
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.